A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Covid-19 Impact on Allergy Diagnostics and Therapeutics Market Global Segmentation and Major Players Analysis 2026 sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
29 December 2020 | 09:50am
StockMarketWire.com - Medical diagnostics company Omega Diagnostics said Abingdon Health had confirmed that they continue to work constructively with the Medicines and Healthcare products Regulatory Agency to try to enable approval for home use and self-test of the AbC-19TM Rapid Test in the UK.
Abingdon also confirmed that wile the DHSC continued to have first refusal for supplies of the AbC-19 rapid test, the UK-RTC is liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.
At 9:50am: [LON:ODX] Omega Diagnostics Group PLC share price was 0p at 56p